These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Multiple receptor tyrosine kinases promote the in vitro phenotype of metastatic human osteosarcoma cell lines. Rettew AN; Young ED; Lev DC; Kleinerman ES; Abdul-Karim FW; Getty PJ; Greenfield EM Oncogenesis; 2012 Nov; 1(11):e34. PubMed ID: 23552467 [TBL] [Abstract][Full Text] [Related]
3. Receptor tyrosine kinases in osteosarcoma: not just the usual suspects. Rettew AN; Getty PJ; Greenfield EM Adv Exp Med Biol; 2014; 804():47-66. PubMed ID: 24924168 [TBL] [Abstract][Full Text] [Related]
4. Receptor Tyrosine Kinases in Osteosarcoma Treatment: Which Is the Key Target? Tian Z; Niu X; Yao W Front Oncol; 2020; 10():1642. PubMed ID: 32984034 [TBL] [Abstract][Full Text] [Related]
5. Specific tyrosine kinase inhibitors regulate human osteosarcoma cells in vitro. Messerschmitt PJ; Rettew AN; Brookover RE; Garcia RM; Getty PJ; Greenfield EM Clin Orthop Relat Res; 2008 Sep; 466(9):2168-75. PubMed ID: 18607665 [TBL] [Abstract][Full Text] [Related]
6. [Expression analysis of protein tyrosine kinases of the FAK (focal adhesion kinase) family in osteosarcoma]. Schröder A; Delling G; Kaiser EA Pathologe; 2002 Sep; 23(5):361-6. PubMed ID: 12376862 [TBL] [Abstract][Full Text] [Related]
7. Small GTP-binding protein, Rho, both increased and decreased cellular motility, activation of matrix metalloproteinase 2 and invasion of human osteosarcoma cells. Matsumoto Y; Tanaka K; Harimaya K; Nakatani F; Matsuda S; Iwamoto Y Jpn J Cancer Res; 2001 Apr; 92(4):429-38. PubMed ID: 11346466 [TBL] [Abstract][Full Text] [Related]
8. Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling. Cantiani L; Manara MC; Zucchini C; De Sanctis P; Zuntini M; Valvassori L; Serra M; Olivero M; Di Renzo MF; Colombo MP; Picci P; Scotlandi K Cancer Res; 2007 Aug; 67(16):7675-85. PubMed ID: 17699771 [TBL] [Abstract][Full Text] [Related]
9. Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma. Chaiyawat P; Klangjorhor J; Settakorn J; Champattanachai V; Phanphaisarn A; Teeyakasem P; Svasti J; Pruksakorn D Transl Oncol; 2017 Oct; 10(5):846-853. PubMed ID: 28881260 [TBL] [Abstract][Full Text] [Related]
11. The effects of genistein on the synthesis and distribution of glycosaminoglycans/proteoglycans by two osteosarcoma cell lines depends on tyrosine kinase and the estrogen receptor density. Nikitovic D; Tsatsakis AM; Karamanos NK; Tzanakakis GN Anticancer Res; 2003; 23(1A):459-64. PubMed ID: 12680249 [TBL] [Abstract][Full Text] [Related]
12. Proteomic quantification of receptor tyrosine kinases involved in the development and progression of colorectal cancer liver metastasis. Vasilogianni AM; Al-Majdoub ZM; Achour B; Peters SA; Rostami-Hodjegan A; Barber J Front Oncol; 2023; 13():1010563. PubMed ID: 36890818 [TBL] [Abstract][Full Text] [Related]
13. Targeting receptor tyrosine kinases in osteosarcoma and Ewing sarcoma: current hurdles and future perspectives. Fleuren ED; Versleijen-Jonkers YM; Boerman OC; van der Graaf WT Biochim Biophys Acta; 2014 Apr; 1845(2):266-76. PubMed ID: 24582852 [TBL] [Abstract][Full Text] [Related]
14. ROCK1 as a potential therapeutic target in osteosarcoma. Liu X; Choy E; Hornicek FJ; Yang S; Yang C; Harmon D; Mankin H; Duan Z J Orthop Res; 2011 Aug; 29(8):1259-66. PubMed ID: 21387396 [TBL] [Abstract][Full Text] [Related]
15. Multiple receptor tyrosine kinase activation attenuates therapeutic efficacy of the fibroblast growth factor receptor 2 inhibitor AZD4547 in FGFR2 amplified gastric cancer. Chang J; Wang S; Zhang Z; Liu X; Wu Z; Geng R; Ge X; Dai C; Liu R; Zhang Q; Li W; Li J Oncotarget; 2015 Feb; 6(4):2009-22. PubMed ID: 25576915 [TBL] [Abstract][Full Text] [Related]
16. WNT5A promotes migration and invasion of human osteosarcoma cells via SRC/ERK/MMP-14 pathway. Wang X; Zhao X; Yi Z; Ma B; Wang H; Pu Y; Wang J; Wang S Cell Biol Int; 2018 May; 42(5):598-607. PubMed ID: 29345412 [TBL] [Abstract][Full Text] [Related]
19. Differential effects of bacterial toxins on mitogenic actions of sodium fluoride and those of aluminum fluoride in human TE85 osteosarcoma cells. Hashimoto H; Lau KH Mol Cell Biochem; 2001 Dec; 228(1-2):91-8. PubMed ID: 11855746 [TBL] [Abstract][Full Text] [Related]
20. The tyrosine kinase inhibitor sorafenib decreases cell number and induces apoptosis in a canine osteosarcoma cell line. Wolfesberger B; Tonar Z; Gerner W; Skalicky M; Heiduschka G; Egerbacher M; Thalhammer JG; Walter I Res Vet Sci; 2010 Feb; 88(1):94-100. PubMed ID: 19665156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]